| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Kevin Hern OK01 | 4 | −$32.0K | Trimmed Sep 2, 26 | |
| Rick Larsen WA02 | 1 | −$8.0K | Sold Oct 6, 25 | |
| Julie Johnson TX32 | 1 | 2 | −$8.0K | Sold Sep 25, 25 |
| Lisa McClain MI09 | 2 | 2 | +$0 | Sold Sep 11, 25 |
| Tim Moore NC14 | 1 | −$8.0K | Sold Sep 10, 25 | |
| Ritchie John Torres NY15 | 1 | −$8.0K | Sold Jul 11, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Sep 2, 26 | Kevin Hern OK01 | Joint | Sell (part) | $1,001 - $15,000 | Sep 25, 26 (23d) | |
| Aug 31, 26 | Kevin Hern OK01 | Self | Sell | $1,001 - $15,000 | Sep 25, 26 (25d) | |
| Aug 27, 26 | Kevin Hern OK01 | Self | Sell (part) | $1,001 - $15,000 | Sep 25, 26 (29d) | |
| Aug 19, 26 | Kevin Hern OK01 | Joint | Sell | $1,001 - $15,000 | Sep 1, 26 (13d) | |
| Oct 6, 25 | Rick Larsen WA02 | Self | Sell | $1,001 - $15,000 | Oct 16, 25 (10d) | |
| Sep 25, 25 | Julie Johnson TX32 | Joint | Sell | $1,001 - $15,000 | Oct 7, 25 (12d) | |
| Sep 23, 25 | Julie Johnson TX32 | Joint | Sell | $1,001 - $15,000 | Aug 5, 26 (316d) | |
| Sep 23, 25 | Julie Johnson TX32 | Joint | Buy | $1,001 - $15,000 | Aug 5, 26 (316d) | |
| Sep 11, 25 | Lisa McClain MI09 | Spouse | Sell | $1,001 - $15,000 | Oct 22, 25 (41d) | |
| Sep 10, 25 | Tim Moore NC14 | Self | Sell | $1,001 - $15,000 | Oct 10, 25 (30d) | |
| Aug 13, 25 | Lisa McClain MI09 | Spouse | Buy | $1,001 - $15,000 | Sep 12, 25 (30d) | |
| Jul 11, 25 | Ritchie John Torres NY15 | Self | Sell | $1,001 - $15,000 | Aug 20, 25 (40d) | |
| Jun 24, 25 | Lisa McClain MI09 | Spouse | Sell | $1,001 - $15,000 | Aug 13, 25 (50d) | |
| Jun 17, 25 | Lisa McClain MI09 | Spouse | Buy | $1,001 - $15,000 | Aug 13, 25 (57d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 23, 2026 | Tsourapas PanagiotisOfficer | Sale at price 92.05 per share. | 10K | $920.48K |
| Aug 5, 2026 | Cahill John TDirector | Sale at price 93.37 per share. | 4.2K | $389.36K |
| Aug 5, 2026 | Cahill John TDirector | Conversion of Exercise of derivative security at price 71.56 per share. | 4.2K | $298.40K |
| Aug 4, 2026 | Wallace Noel RChief Executive Officer | Sale at price 91.92 - 92.52 per share. | 322K | $29.70M |
| Aug 4, 2026 | Wallace Noel RChief Executive Officer | Conversion of Exercise of derivative security at price 72.29 per share. | 322K | $23.28M |
| Jun 30, 2026 | Bilbrey John P.Director | Stock Award(Grant) at price 89.45 per share. | 265 | $23.70K |
| Jun 30, 2026 | Norrington Lorrie MDirector | Stock Award(Grant) at price 89.45 per share. | 293 | $26.21K |
| Jun 30, 2026 | Newman BrianDirector | Stock Award(Grant) at price 89.45 per share. | 209 | $18.70K |
| May 14, 2026 | Malcolm GregoryOfficer | Sale at price 88.44 per share. | 2.3K | $203.41K |
| May 10, 2026 | Bilbrey John P.Director | Stock Award(Grant) at price 0.00 per share. | 2.1K | — |
| May 10, 2026 | Harris C. Martin M.D.Director | Stock Award(Grant) at price 0.00 per share. | 1.6K | — |
| May 10, 2026 | Norrington Lorrie MDirector | Stock Award(Grant) at price 0.00 per share. | 2.1K | — |
| May 10, 2026 | Boerner Christopher SDirector | Stock Award(Grant) at price 0.00 per share. | 1.4K | — |
| May 10, 2026 | Nelson Kimberly A.Director | Stock Award(Grant) at price 0.00 per share. | 2.1K | — |
| May 10, 2026 | Hund-Mejean MartinaDirector | Stock Award(Grant) at price 0.00 per share. | 2.1K | — |
| May 10, 2026 | Cahill John TDirector | Stock Award(Grant) at price 0.00 per share. | 2.1K | — |
| May 10, 2026 | Newman BrianDirector | Stock Award(Grant) at price 0.00 per share. | 2.1K | — |
| May 10, 2026 | Edwards Lisa MarieDirector | Stock Award(Grant) at price 0.00 per share. | 2.1K | — |
| May 6, 2026 | Massey SallyOfficer | Sale at price 87.41 per share. | 8.6K | $751.63K |
| Mar 31, 2026 | Bilbrey John P.Director | Stock Award(Grant) at price 89.05 per share. | 266 | $23.69K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 14.3 | 9.8 | -14.0 | 0.2 | 5.6 | 1.7 | -0.4 | -1.6 | -5.0 | 5.5 | +13.9% | ||
| 2025 | -4.6 | 5.2 | 2.8 | -1.6 | 0.8 | -2.2 | -7.8 | 0.3 | -4.9 | -3.6 | 4.3 | -1.7 | −13.1% |
| 2024 | 5.6 | 2.8 | 4.1 | 2.1 | 1.1 | 4.4 | 2.2 | 7.4 | -2.5 | -9.7 | 3.1 | -5.9 | +14.1% |
| 2023 | -5.4 | -1.7 | 2.5 | 6.2 | -6.8 | 3.6 | -1.0 | -3.7 | -3.2 | 5.6 | 4.9 | 1.2 | +1.2% |
| 2022 | -3.4 | -6.7 | -1.5 | 1.6 | 2.3 | 1.7 | -1.7 | -0.7 | -10.2 | 5.1 | 4.9 | 1.7 | −7.7% |
| 2021 | -8.8 | -3.6 | 4.8 | 2.4 | 3.8 | -2.9 | -2.3 | -1.9 | -3.0 | 0.8 | -1.5 | 13.8 | −0.2% |
| 2020 | 7.2 | -8.4 | -1.8 | 5.9 | 2.9 | 1.3 | 5.4 | 2.7 | -2.7 | 2.3 | 8.6 | -0.2 | +24.2% |
| 2019 | 8.7 | 1.8 | 4.1 | 6.2 | -4.4 | 2.9 | 0.1 | 3.4 | -0.9 | -6.7 | -1.1 | 1.5 | +15.7% |
| 2018 | -1.6 | -7.1 | 3.9 | -9.0 | -3.3 | 2.7 | 3.4 | -0.9 | 0.8 | -11.1 | 6.7 | -6.3 | −21.1% |
| 2017 | -1.3 | 13.0 | 0.3 | -1.6 | 6.0 | -2.9 | -2.6 | -0.8 | 1.7 | -3.3 | 2.8 | 4.1 | +15.3% |
| 2016 | 1.4 | -2.8 | 7.6 | 0.4 | -0.7 | 4.0 | 1.7 | -0.1 | -0.3 | -3.7 | -8.6 | 0.3 | −1.8% |
| 2015 | -2.4 | 4.9 | -2.1 | -3.0 | -0.7 | -2.1 | 4.0 | -7.7 | 1.0 | 4.6 | -1.0 | 1.4 | −3.7% |
| 2014 | -6.1 | 2.6 | 3.2 | 3.7 | 1.6 | -0.3 | -7.0 | 2.1 | 0.8 | 2.5 | 4.1 | -0.6 | +6.1% |
| 2013 | 2.7 | 6.6 | 3.1 | 1.2 | -3.1 | -1.0 | 4.5 | -3.5 | 2.6 | 9.2 | 1.7 | -0.9 | +24.8% |
| 2012 | -1.8 | 2.7 | 4.9 | 1.2 | -0.6 | 5.9 | 3.1 | -1.0 | 0.9 | -2.1 | 3.4 | -3.6 | +13.2% |
| 2011 | -4.5 | 2.3 | 2.9 | 4.4 | 3.8 | -0.1 | -3.5 | 6.6 | -1.4 | 1.9 | 1.3 | 1.0 | +15.0% |
| 2010 | -2.6 | 3.6 | 2.8 | -1.4 | -7.1 | 0.9 | 0.3 | -6.5 | 4.1 | 0.3 | -0.7 | 5.0 | −2.2% |
| 2009 | -5.1 | -7.5 | -2.0 | 0.0 | 11.8 | 7.3 | 2.4 | 0.4 | 4.9 | 3.1 | 7.1 | -2.4 | +19.9% |
| 2008 | -1.9 | -0.5 | 2.4 | -9.3 | 5.2 | -7.1 | 7.5 | 2.4 | -0.9 | -16.7 | 3.7 | 5.3 | −12.1% |
| 2007 | 4.7 | -1.3 | -0.9 | 1.4 | -1.2 | -3.2 | 1.8 | 0.5 | 7.5 | 6.9 | 5.0 | -2.6 | +19.5% |
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Buy / hold / sell counts